Sherbrooke Park Advisers’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$57.5K Buy
2025
Q1
Sell
2024
Q4
$177K Buy
2024
Q3
Sell
2024
Q2
$251K Buy